Adalimumab with Methotrexate versus Adalimumab Monotherapy in Psoriasis

被引：0
|
作者：
Weiss, Johannes M.
机构：
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2022年 / 20卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：906 / 906
页数：1
相关论文
共 50 条
  • [1] Comparison of treatment for psoriasis with methotrexate and adalimumab
    不详
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 189 (03) : e64 - e64
  • [2] Adalimumab combined with methotrexate versus adalimumab monotherapy in psoriasis: Three-year follow-up data of a single-blind randomized controlled trial
    van Huizen, Astrid M.
    van der Kraaij, Gayle E.
    Busard, Celine I.
    Ouwerkerk, Wouter
    van den Reek, Juul M. P. A.
    Menting, Stef P.
    Prens, Errol P.
    Rispens, Theo
    de Vries, Annick
    de Jong, Elke M. G. J.
    Lambert, Jo
    van Doorn, Martijn B. A.
    Spuls, Phyllis I.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, : 1815 - 1824
  • [3] Adalimumab with Methotrexate vs. Adalimumab Monotherapy in Psoriasis: First-Year Results of a Single-Blind Randomized Controlled Trial
    van der Kraaij, Gayle
    Busard, Celine
    van den Reek, Juul
    Menting, Stef
    Musters, Annelie
    Hutten, Barbara
    de Rie, Menno
    Ouwerkerk, Wouter
    Van Bezooijen, Sun-Jine
    Prens, Errol
    Rispens, Theo
    de Vries, Annick
    de Jong, Elke
    de Kort, Wim
    Lambert, Jo
    van Doorn, Martijn
    Spuls, Phyllis
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (09) : 2375 - +
  • [4] Bimekizumab versus Adalimumab in Plaque Psoriasis
    Warren, R. B.
    Blauvelt, A.
    Bagel, J.
    Papp, K. A.
    Yamauchi, P.
    Armstrong, A.
    Langley, R. G.
    Vanvoorden, V.
    De Cuyper, D.
    Cioffi, C.
    Peterson, L.
    Cross, N.
    Reich, K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (02): : 130 - 141
  • [5] Bimekizumab versus Adalimumab in Plaque Psoriasis
    Griffith, Shantelle K.
    Ahn, Grace S.
    Wu, Jashin J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (12): : 1149 - 1150
  • [6] Effects of adalimumab monotherapy versus adalimumab plus betamethasone/calcipotriol combination therapy on patient-reported outcomes in psoriasis patients
    Thaci, Diamant
    Xie, Jipan
    Mulani, Parvez
    Gupta, Shiraz
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (03) : AB127 - AB127
  • [7] Effects of adalimumab monotherapy versus adalimumab plus betamethasone/calcipotriol on patient-reported outcomes in psoriasis patients with psoriatic arthritis
    Thaci, Diamant
    Xie, Jipan
    Mulani, Parvez
    Gupta, Shiraz
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (03) : AB135 - AB135
  • [8] Longterm Use of Adalimumab as Monotherapy Following Attainment of Low Disease Activity with Adalimumab plus Methotrexate
    Keystone, Edward
    Breedveld, Ferdinand
    Kupper, Hartmut
    Liu, Shufang
    Florentinus, Stefan
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 967 - 968
  • [9] Adalimumab monotherapy vs. adalimumab and methotrexate combination therapy in psoriasis: first-year results on drug survival, effectiveness, safety and immunogenicity
    Van der Kraaij, G.
    Busard, C.
    van den Reek, J.
    Menting, S.
    van Bezooijen, S. -J.
    de Jong, E.
    de Kort, W.
    Prens, E.
    van Doorn, M.
    Spuls, P.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 : 14 - 15
  • [10] Impact of methotrexate and adalimumab on immune function of patients with psoriasis
    Todberg, Tanja
    Loft, Nikolai
    Moller, Dina Leth
    Ostrowski, Sisse Rye
    Nielsen, Susanne Dam
    Skov, Lone
    DERMATOLOGIC THERAPY, 2022, 35 (03)
12345